FABPulous develops ultra-rapid point-of-care diagnostic tests which can be used in the first line medical care for the determination of acute tissue injury. These tests provide rapid and accurate diagnosis and benefit both the patient (live-saving) as well as the healthcare sector, the insurance industry, governments and society in general (cost-saving).